The present invention relates to humanized antibodies and {HEAD ~ binding proteins} thereof, capable of binding to T cells exhibiting {TAIL ~ particular variable beta chains}, and particularly those subpopulations expressing human V beta 5.2 and 5.3, and V beta 8.1 
The present invention relates to humanized antibodies and { HEAD ~ binding proteins } thereof , capable of binding to T cells exhibiting { TAIL ~ particular variable beta chains } , and particularly those subpopulations expressing human V beta 5.2 and 5.3 , and V beta 8.1
OTH OTH OTH OTH OTH OTH OTH OTH HEAD HEAD HEAD HEAD HEAD HEAD OTH OTH OTH OTH OTH OTH OTH OTH OTH TAIL TAIL TAIL TAIL TAIL TAIL TAIL TAIL OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH OTH